Extracellular ATP: A central player in the regulation of vascular smooth muscle phenotype. Focus on "Dual role of PKA in phenotype modulation of vascular smooth muscle cells by extracellular ATP"

American Journal of Physiology - Cell Physiology

Volumn 287, Issue 2 56-2, 2004, Pages

  Erlinge, David ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE 5' O (3 THIOTRIPHOSPHATE); ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ALPHA ACTIN; CELL DNA; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; INOSITOL 1,4,5 TRISPHOSPHATE; MITOGEN ACTIVATED PROTEIN KINASE 1; PURINE P2X2 RECEPTOR; PURINE P2Y11 RECEPTOR; PURINE P2Y2 RECEPTOR; PURINE P2Y6 RECEPTOR;

CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CONCENTRATION RESPONSE; DNA BINDING; DNA SYNTHESIS; EDITORIAL; ENZYME ACTIVATION; ENZYME ACTIVITY; EXTRACELLULAR SPACE; GENE EXPRESSION REGULATION; MITOGENESIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; RECEPTOR DOWN REGULATION; RECEPTOR INTRINSIC ACTIVITY; RECEPTOR UPREGULATION; SECOND MESSENGER; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION;

ADENOSINE TRIPHOSPHATE; ANIMALS; CYCLIC AMP-DEPENDENT PROTEIN KINASES; EXTRACELLULAR SPACE; HUMANS; MUSCLE, SMOOTH, VASCULAR; PHENOTYPE;

EID: 3242736640     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.00217.2004     Document Type: Editorial

References (22)

1. Bo X, Sexton A, Xiang Z, Nori SL, and Burnstock G. Pharmacological and histochemical evidence for P2X receptors in human umbilical vessels. Eur J Pharmacol 353: 59-65, 1998.
2. Bodin P, Bailey D, and Burnstock G. Increased flow-induced ATP release from isolated vascular endothelial cells but not smooth muscle cells. Br J Pharmacol 103: 1203-1205, 1991.
3. Burnstock G. Purinergic signaling and vascular cell proliferation and death. Arterioscler Thromb Vasc Biol 22: 364-373, 2002.
4. Communi D, Govaerts C, Parmentier M, and Boeynaems JM. Cloning of a human purinergic P2Y receptor coupled to phospholipase C and adenylyl cyclase. J Biol Chem 272: 31969-31973, 1997.
5. D'Souza FM, Sparks RL, Chen H, Kadowitz PJ, and Jeter JR Jr. Mechanism of eNOS gene transfer inhibition of vascular smooth muscle cell proliferation. Am J Physiol Cell Physiol 294: C191-C199, 2003.
6. Erlinge D, Hou M, Webb TE, Barnard E, and Möller S. Phenotype changes of the vascular smooth muscle cell regulate P2 receptor expression as measured by quantitative RT-PCR. Biochem Biophys Res Commun 248: 864-870, 1998.
7. Erlinge D, Yoo H, Edvinsson L, Reis DJ, and Wahlestedt C. Mitogenic effects of ATP on vascular smooth muscle cells vs. other growth factors and sympathetic cotransmitters. Am J Physiol Heart Circ Physiol 265: H1089-H1097, 1993.
8. Hogarth DK, Sandbo N, Taurin S, Kolenko V, Miano JM, and Dulin NO. Dual role of PKA in the phenotypic modulation of vascular smooth muscle cells by extracellular ATP. Am J Physiol Cell Physiol 287: C449-C456, 2004.
9. 6 receptors. Am J Physiol Heart Circ Physiol 282: H784-H792, 2002.
10. Hou M, Möller S, Edvinsson L, and Erlinge D. Cytokines induce upregulation of vascular P2Y2-receptors and increase mitogenic responses to UTP and ATP. Arterioscler Thromb Vasc Biol 20: 2064-2069, 2000.
11. Hou M, Móller S, Edvinsson L, and Erlinge D. MAPKK-dependent growth factor induced upregulation of P2Y2-receptors in vascular smooth muscle cells. Biochem Biophys Res Commun 258: 648-652, 1999.
12. Inbe H, Watanabe S, Miyawaki M, Tanabe E, and Encinas JA. Identification and characterization of a cell-surface receptor, P2Y15, for AMP and adenosine, J Biol Chem 279: 19790-19799, 2004. First published March 4, 2004; 10.1074/jbc.M400360200.
13. Ito C, Kusano E, Furukawa Y, Yamamoto H, Takeda S, Akimoto T, Iimura O, Ando Y, Asano Ito C Y, Kusano E, Furukawa Y, Yamamoto H, Takeda S, Akimoto T, Iimura O, and Ando Y. Modulation of the erythropoietin-induced proliferative pathway by cAMP in vascular smooth muscle cells. Am J Physiol Cell Physiol 283: C1715-C1721, 2002.
14. Malam-Souley R, Campan M, Gadeau A, and Desgranges C. Exogenous ATP induces a limited cell cycle progression of arterial smooth muscle cells. Am J Physiol Cell Physiol 264: C783-C788, 1993.
15. Post SR, Rump C, Zambon A, Hughes RJ, Buda MD, Jacobson P, Kao CC, and Insel P. ATP activates cAMP production via multiple purinergic receptors in MDCK-D1 epithelial cells. J Biol Chem 273: 23093-23097, 1998.
16. Ralevic V and Burnstock G. Receptors for purines and pyrimidines. Pharmacol Rev 50: 413-492, 1998.
17. 2 purinoceptor in intimal lesions of the rat aorta. Arterioscler Thromb Vasc Biol 17: 3602-3610, 1997.
18. Thyberg J. Differentiated properties and proliferation of arterial smooth muscle cells in culture. Int Rev Cytol 169: 183-265, 1996.
19. 6-like receptor in arteries. Mol Pharmacol 62: 1438-1445, 2002.
20. Wang DJ, Huang NN, and Heppel LA. Extracellular ATP and ADP stimulate proliferation of porcine aortic smooth muscle cells. J Cell Physiol 153: 221-233, 1992.
21. Wang L, Karlsson L, Moses S, Hultgårdb-Nilsson A, Andersson M, Borna C, Gudbjartsson T, Jern S, and Erlinge D. Specific P2 receptor expression in human vascular smooth muscle and endothelial cells. J Cardiovasc Pharmacol 40: 841-853, 2002.
22. Wang L, Andersson M, Karlsson L, Watson MA, Cousens D, Jern S, and Erlinge D. Increase in mitogenic and decrease in contractile P2 receptors by fluid shear stress in intact human conduit vessels. Arterioscler Thromb Vasc Biol 23: 1370-1376, 2003.